Detalhe da pesquisa
1.
Metabolomic Profiling of the Effects of Dapagliflozin in Heart Failure With Reduced Ejection Fraction: DEFINE-HF.
Circulation
; 146(11): 808-818, 2022 09 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-35603596
2.
Association Between Change in Ambulatory Pulmonary Artery Pressures and Natriuretic Peptides in Patients with Heart Failure: Results From the EMBRACE-HF Trial.
J Card Fail
; 29(9): 1324-1328, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37230315
3.
Empagliflozin Effects on Pulmonary Artery Pressure in Patients With Heart Failure: Results From the EMBRACE-HF Trial.
Circulation
; 143(17): 1673-1686, 2021 04 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-33550815
4.
Dapagliflozin effects on lung fluid volumes in patients with heart failure and reduced ejection fraction: Results from the DEFINE-HF trial.
Diabetes Obes Metab
; 23(6): 1426-1430, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33606921
5.
Dapagliflozin Effects on Biomarkers, Symptoms, and Functional Status in Patients With Heart Failure With Reduced Ejection Fraction: The DEFINE-HF Trial.
Circulation
; 140(18): 1463-1476, 2019 10 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-31524498
6.
Targeted Metabolomic Profiling of Dapagliflozin in Heart Failure With Preserved Ejection Fraction: The PRESERVED-HF Trial.
JACC Heart Fail
; 2024 Apr 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38639697
7.
Dapagliflozin Improves Heart Failure Symptoms and Physical Limitations Across the Full Range of Ejection Fraction: Pooled Patient-Level Analysis From DEFINE-HF and PRESERVED-HF Trials.
Circ Heart Fail
; 16(7): e009837, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37203441
8.
Effect of Dapagliflozin on 6-Minute Walk Distance in Heart Failure With Preserved Ejection Fraction: PRESERVED-HF.
Circ Heart Fail
; 16(11): e010633, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37869881
9.
Dapagliflozin and Kidney Outcomes in Hospitalized Patients with COVID-19 Infection: An Analysis of the DARE-19 Randomized Controlled Trial.
Clin J Am Soc Nephrol
; 17(5): 643-654, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35483733
10.
The SGLT2 inhibitor dapagliflozin in heart failure with preserved ejection fraction: a multicenter randomized trial.
Nat Med
; 27(11): 1954-1960, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34711976
11.
Dapagliflozin in patients with cardiometabolic risk factors hospitalised with COVID-19 (DARE-19): a randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet Diabetes Endocrinol
; 9(9): 586-594, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34302745
12.
Association Between Change in Ambulatory Hemodynamic Pressures and Symptoms of Heart Failure.
Circ Heart Fail
; 14(11): e008446, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34696602
13.
Omega-3 fatty acids in cardiac biopsies from heart transplantation patients: correlation with erythrocytes and response to supplementation.
Circulation
; 110(12): 1645-9, 2004 Sep 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-15353491
14.
The impact of age, body mass index, and fish intake on the EPA and DHA content of human erythrocytes.
Lipids
; 40(4): 343-7, 2005 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-16028715